Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
Displaying 1 - 10 of 15 Clinical Trials
ID/Name Source Type
A Cardiac Safety Study of Galantamine in the Treatment of Alzheimer's Disease.
NCT00309725 clinicaltrials.gov Clinical Trial
A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive Impairment
NCT00240695 clinicaltrials.gov Clinical Trial
A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions
NCT00870974 clinicaltrials.gov Clinical Trial
A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal Dementia
NCT00416169 clinicaltrials.gov Clinical Trial
A Placebo-controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Vascular Dementia
NCT00035191 clinicaltrials.gov Clinical Trial
A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease
NCT00253201 clinicaltrials.gov Clinical Trial
A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment
NCT00236431 clinicaltrials.gov Clinical Trial
A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment
NCT00236574 clinicaltrials.gov Clinical Trial
Evaluation of [123I] AV51 and SPECT as a Marker of Beta-Amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects
NCT00556660 clinicaltrials.gov Clinical Trial
Evaluation of [18F] FEPPA and PET Imaging as a Marker of Inflammation in Subjects With Neurological Conditions
NCT00970333 clinicaltrials.gov Clinical Trial